Filing Details

Accession Number:
0000873303-10-000030
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-07-07 13:00:00
Reporting Period:
2010-03-24
Filing Date:
2010-07-07
Accepted Time:
2010-07-07 13:04:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
873303 Avi Biopharma Inc AVII Pharmaceutical Preparations (2834) 930797222
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1321265 Leslie Hudson 3450 Monte Villa Parkway, Suite 101
Bothell WA 98021
Former Ceo No Yes No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-03-24 21,427 $1.49 435,897 Yes 4 S Direct
Common Stock Disposition 2010-06-24 51,338 $1.24 384,559 Yes 4 S Direct
Common Stock Acquisiton 2010-07-02 128,911 $0.92 513,470 No 4 M Direct
Common Stock Disposition 2010-07-02 47,270 $1.55 466,200 No 4 S Direct
Common Stock Disposition 2010-07-02 21,172 $1.56 445,028 No 4 S Direct
Common Stock Disposition 2010-07-02 48,928 $1.57 396,100 No 4 S Direct
Common Stock Disposition 2010-07-02 6,341 $1.58 389,759 No 4 S Direct
Common Stock Disposition 2010-07-02 3,700 $1.59 386,059 No 4 S Direct
Common Stock Disposition 2010-07-02 1,500 $1.60 384,559 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
Yes 4 S Direct
Yes 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2010-07-02 128,911 $0.00 128,911 $0.92
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
221,089 2019-02-10 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Incentive Stock Option (right to buy) $1.09 2009-02-08 2018-02-08 366,972 366,972 Direct
Common Stock Incentive Stock Option (right to buy) $1.45 2011-02-09 2020-02-09 68,965 68,965 Direct
Common Stock Non-Qualified Stock Option (right to buy) $1.09 2009-02-08 2018-02-08 300,028 300,028 Direct
Common Stock Non-Qualified Stock Option (right to buy) $1.45 2011-02-09 2020-02-09 531,035 531,035 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2018-02-08 366,972 366,972 Direct
2020-02-09 68,965 68,965 Direct
2018-02-08 300,028 300,028 Direct
2020-02-09 531,035 531,035 Direct
Footnotes
  1. The Restricted Stock Holder has elected to pay for payroll taxes for restricted stock awards by way of a stock swap of a total 21,427 restricted stock awards for the 124,324 restricted stock awards granted in 2009. The remaining 102,897 remains with the optionee.
  2. The Restricted Stock Holder has elected to pay for payroll taxes for restricted stock awards by way of a stock swap of a total 51,338 restricted stock awards for the 333,000 restricted stock awards granted in 2008. The remaining 281,662 remains with the optionee.
  3. This transaction was a Same Day Sale. The optionholder exercised 128,911 Non-Qualified Options and the shares were sold on the same day.
  4. The original option vested 1/3 each year over 3 years. On 4/20/2010, the option had 116,667 fully vested shares and the Company approved a vesting acceleration of the remaining 233,333 shares.
  5. Option Grant vests 25% per year on grant date with all shares vesting four years from date of grant.
  6. The Stock Option Grant vest as follows: 1/3 vest one year from date of grant and 1/3 each year thereafter until all shares vest three years from grant date.